US Patent 10172922 Rapid-acting insulin compositions
Patent 10172922 was granted and assigned to Eli Lilly and Company on January, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10172922 Rapid-acting insulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.